HK Stock MarketDetailed Quotes

08622 HUAKANG BIOMED

Watchlist
  • 0.183
  • -0.002-1.08%
Market Closed Nov 15 16:08 CST
91.59MMarket Cap-14076P/E (TTM)

HUAKANG BIOMED Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
3.95%11.92M
-2.77%24.63M
-5.21%17.77M
-2.81%11.47M
-2.36%5.76M
-3.05%25.33M
0.98%18.75M
-3.08%11.8M
20.70%5.9M
18.94%26.13M
Operating income
3.95%11.92M
-2.77%24.63M
-5.21%17.77M
-2.81%11.47M
-2.36%5.76M
-3.05%25.33M
0.98%18.75M
-3.08%11.8M
20.70%5.9M
18.94%26.13M
Cost of sales
-0.20%-3.93M
-1.43%-8.54M
-1.03%-6.1M
5.34%-3.92M
8.50%-1.88M
12.98%-8.42M
10.53%-6.04M
10.09%-4.14M
-48.16%-2.06M
-33.41%-9.67M
Operating expenses
-0.20%-3.93M
-1.43%-8.54M
-1.03%-6.1M
5.34%-3.92M
8.50%-1.88M
12.98%-8.42M
10.53%-6.04M
10.09%-4.14M
-48.16%-2.06M
-33.41%-9.67M
Gross profit
5.90%7.99M
-4.85%16.09M
-8.17%11.67M
-1.45%7.54M
0.94%3.88M
2.78%16.91M
7.56%12.71M
1.19%7.66M
9.80%3.84M
11.81%16.46M
Selling expenses
-3.67%-3.9M
3.73%-8.62M
0.31%-6.14M
6.46%-3.76M
13.72%-1.87M
-7.25%-8.95M
-14.99%-6.16M
-6.85%-4.02M
-7.87%-2.17M
-17.15%-8.35M
Administrative expenses
-1.24%-4.26M
-0.72%-9.87M
0.23%-6M
-9.25%-4.21M
-1.62%-1.81M
-4.81%-9.8M
8.30%-6.01M
10.69%-3.85M
17.17%-1.79M
8.22%-9.35M
Research and development expenses
-24.95%-2M
-2.82%-2.55M
-22.60%-2.43M
-19.15%-1.6M
-11.56%-743K
-1.89%-2.48M
-18.51%-1.98M
-5.67%-1.34M
-20.65%-666K
-8.17%-2.44M
Impairment and provision
75.81%-60K
-372.65%-1.76M
-28.01%-521K
-29.17%-248K
----
41.44%-373K
36.90%-407K
22.89%-192K
96.67%-2K
80.91%-637K
-Other impairment is provision
75.81%-60K
-372.65%-1.76M
-28.01%-521K
-29.17%-248K
----
41.44%-373K
36.90%-407K
22.89%-192K
96.67%-2K
18.33%-637K
Operating interest expense
----
----
42.22%-26K
----
61.11%-7K
----
---45K
23.26%-33K
30.77%-18K
-37.84%-102K
Special items of operating profit
-43.81%499K
-43.52%985K
-45.77%943K
-11.47%888K
-45.76%96K
237.98%1.74M
325.18%1.74M
582.31%1M
-5.85%177K
116.80%516K
Operating profit
-24.93%-1.73M
-94.07%-5.73M
-1,562.67%-2.49M
-76.98%-1.38M
25.77%-458K
24.37%-2.95M
92.49%-150K
59.40%-782K
44.56%-617K
65.56%-3.9M
Financing cost
-233.33%-50K
3.64%-53K
----
---15K
----
---55K
----
----
----
----
Earning before tax
-27.16%-1.78M
-92.28%-5.78M
-1,562.67%-2.49M
-78.90%-1.4M
25.77%-458K
22.96%-3.01M
92.72%-150K
59.40%-782K
44.56%-617K
65.68%-3.9M
Tax
----
----
99.26%-3K
64.78%-56K
12.50%-56K
78.55%-68K
-43.11%-405K
-29.27%-159K
-77.78%-64K
-24.31%-317K
After-tax profit from continuing operations
-22.27%-1.78M
-88.03%-5.78M
-349.91%-2.5M
-54.62%-1.46M
24.52%-514K
27.13%-3.08M
76.32%-555K
54.08%-941K
40.73%-681K
63.71%-4.22M
Earning after tax
-22.27%-1.78M
-88.03%-5.78M
-349.91%-2.5M
-54.62%-1.46M
24.52%-514K
27.13%-3.08M
76.32%-555K
54.08%-941K
40.73%-681K
63.71%-4.22M
Profit attributable to shareholders
-22.27%-1.78M
-88.03%-5.78M
-349.91%-2.5M
-54.62%-1.46M
24.52%-514K
27.13%-3.08M
76.32%-555K
54.08%-941K
40.73%-681K
63.71%-4.22M
Basic earnings per share
-8.57%-0.0038
-82.89%-0.0139
-361.54%-0.006
-45.83%-0.0035
29.41%-0.0012
28.30%-0.0076
77.59%-0.0013
52.94%-0.0024
41.38%-0.0017
63.57%-0.0106
Diluted earnings per share
-8.57%-0.0038
-82.89%-0.0139
-361.54%-0.006
-45.83%-0.0035
29.41%-0.0012
28.30%-0.0076
77.59%-0.0013
52.94%-0.0024
41.38%-0.0017
63.57%-0.0106
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited
--
--
--
CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited
--
--
--
CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover 3.95%11.92M-2.77%24.63M-5.21%17.77M-2.81%11.47M-2.36%5.76M-3.05%25.33M0.98%18.75M-3.08%11.8M20.70%5.9M18.94%26.13M
Operating income 3.95%11.92M-2.77%24.63M-5.21%17.77M-2.81%11.47M-2.36%5.76M-3.05%25.33M0.98%18.75M-3.08%11.8M20.70%5.9M18.94%26.13M
Cost of sales -0.20%-3.93M-1.43%-8.54M-1.03%-6.1M5.34%-3.92M8.50%-1.88M12.98%-8.42M10.53%-6.04M10.09%-4.14M-48.16%-2.06M-33.41%-9.67M
Operating expenses -0.20%-3.93M-1.43%-8.54M-1.03%-6.1M5.34%-3.92M8.50%-1.88M12.98%-8.42M10.53%-6.04M10.09%-4.14M-48.16%-2.06M-33.41%-9.67M
Gross profit 5.90%7.99M-4.85%16.09M-8.17%11.67M-1.45%7.54M0.94%3.88M2.78%16.91M7.56%12.71M1.19%7.66M9.80%3.84M11.81%16.46M
Selling expenses -3.67%-3.9M3.73%-8.62M0.31%-6.14M6.46%-3.76M13.72%-1.87M-7.25%-8.95M-14.99%-6.16M-6.85%-4.02M-7.87%-2.17M-17.15%-8.35M
Administrative expenses -1.24%-4.26M-0.72%-9.87M0.23%-6M-9.25%-4.21M-1.62%-1.81M-4.81%-9.8M8.30%-6.01M10.69%-3.85M17.17%-1.79M8.22%-9.35M
Research and development expenses -24.95%-2M-2.82%-2.55M-22.60%-2.43M-19.15%-1.6M-11.56%-743K-1.89%-2.48M-18.51%-1.98M-5.67%-1.34M-20.65%-666K-8.17%-2.44M
Impairment and provision 75.81%-60K-372.65%-1.76M-28.01%-521K-29.17%-248K----41.44%-373K36.90%-407K22.89%-192K96.67%-2K80.91%-637K
-Other impairment is provision 75.81%-60K-372.65%-1.76M-28.01%-521K-29.17%-248K----41.44%-373K36.90%-407K22.89%-192K96.67%-2K18.33%-637K
Operating interest expense --------42.22%-26K----61.11%-7K-------45K23.26%-33K30.77%-18K-37.84%-102K
Special items of operating profit -43.81%499K-43.52%985K-45.77%943K-11.47%888K-45.76%96K237.98%1.74M325.18%1.74M582.31%1M-5.85%177K116.80%516K
Operating profit -24.93%-1.73M-94.07%-5.73M-1,562.67%-2.49M-76.98%-1.38M25.77%-458K24.37%-2.95M92.49%-150K59.40%-782K44.56%-617K65.56%-3.9M
Financing cost -233.33%-50K3.64%-53K-------15K-------55K----------------
Earning before tax -27.16%-1.78M-92.28%-5.78M-1,562.67%-2.49M-78.90%-1.4M25.77%-458K22.96%-3.01M92.72%-150K59.40%-782K44.56%-617K65.68%-3.9M
Tax --------99.26%-3K64.78%-56K12.50%-56K78.55%-68K-43.11%-405K-29.27%-159K-77.78%-64K-24.31%-317K
After-tax profit from continuing operations -22.27%-1.78M-88.03%-5.78M-349.91%-2.5M-54.62%-1.46M24.52%-514K27.13%-3.08M76.32%-555K54.08%-941K40.73%-681K63.71%-4.22M
Earning after tax -22.27%-1.78M-88.03%-5.78M-349.91%-2.5M-54.62%-1.46M24.52%-514K27.13%-3.08M76.32%-555K54.08%-941K40.73%-681K63.71%-4.22M
Profit attributable to shareholders -22.27%-1.78M-88.03%-5.78M-349.91%-2.5M-54.62%-1.46M24.52%-514K27.13%-3.08M76.32%-555K54.08%-941K40.73%-681K63.71%-4.22M
Basic earnings per share -8.57%-0.0038-82.89%-0.0139-361.54%-0.006-45.83%-0.003529.41%-0.001228.30%-0.007677.59%-0.001352.94%-0.002441.38%-0.001763.57%-0.0106
Diluted earnings per share -8.57%-0.0038-82.89%-0.0139-361.54%-0.006-45.83%-0.003529.41%-0.001228.30%-0.007677.59%-0.001352.94%-0.002441.38%-0.001763.57%-0.0106
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited------CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited------CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data